BRS/RA Integrated Conference |
|||
| Tuesday 13th May | |||
| 8.00 | REGISTRATION AND COFFEE | |
|
9.00-10.00 |
Lomond Auditorium MAKING RENAL REPLACEMENT THERAPY BETTER Chair: Lisa Burnapp & Donal O’Donoghue Peritoneal Dialysis Haemodialysis
Transplantation |
Carron GENETICS AND RENAL DEVELOPMENT Uroplakins – Key players in renal development O62 Investigating the pathway from mutant complement factor H to Endothelial Injury in Haemolytic Uraemic Syndrome O63 Investigation of Coronary Artery Disease risk alleles for association with Diabetic Nephropathy |
| 10.00-10.30 | COFFEE & EXHIBITION POSTERS | |
|
Lomond Auditorium |
Alsh |
Boisdale |
Carron |
Dochart |
|
10.30- 12.00 |
PRESENTATION FROM THE AEG RAINE AWARD WINNER Finding genes for diabetic kidney disease: Back to the future O64 Symptom trajectories in conservatively-managed CKD – understanding the impact of symptoms over time O65 Predicting Encapsulating Peritoneal Sclerosis: can this be improved by CT scanning and measurement of dialysate cytokines? O66 Truncations in the Carboxyl terminus of Human DNA 3’ 5’ Exonuclease TREX1 Cause Autosomal Dominant Retinal Vasculopathy with Cerebral Leukodystrophy O67 Macrophages expressing hemoxygenase-1 protect from renal ischaemia-reperfusion injury |
NON MEDICAL LED CARE O68 Art during HD treatment improves patients’ mental health and sense of wellbeing Non medical prescribing O69 Successful Management of Anaemia in HD Patients by a Pharmacist Prescriber Innovation and practice in the management of renal bone disease 070 Dietetic management of phosphate binder therapy in HD patients: Impact on binder elemental calcium load and costs |
YOUNG PEOPLE ON RENAL REPLACEMENT THERAPY O71 Action Learning Set on Transition of Adolescent Renal Transplant Recipients Invited Speaker: Paul Harden, |
CPD Session: Dialysis What four steps should be taken to improve mortality rates of haemodialysis patients in the UK What needs to be done to improve patient safety on haemodialysis? Are clinical outcomes better with haemodiafiltration or high flux haemodialysis? |
CLINICAL NEPHROLOGY Chair: Charles Pusey & Neil Sheerin O73 Rituximab based on cyclophosphamide-sparing induction therapy in ANCA-associated vasculitis with glomerulonephritis O74 Hereditary renal amyloidosis associated with mutant fibrogen Aa-chain: clinical presentation, molecular basis, histological features and outcome of RRT O75 Clinical characteristics and histological findings in liver transplant recipients who have undergone renal biopsy O76 Clinical and immunological effects of Infliximab as additional therapy for anti-neutrophil cytoplasm antibody associated vasculitis O77 Clinical characteristics of 13 Greek-Cypriot families with three heterozygous mutations in the COL4A3/COL4A4 genes, showing famial microscopic hematuria, thin glomerular basement membrane nephropathy and late progression to chronic or end-stage renal failure with focal segmental glomerulosclerosis |
| 12.00-13.30 | LUNCH & EXHIBITION MODERATED POSTER SESSION | |||
|
13.30-15.00 |
Lomond Auditorium WHAT MATTERS TO PATIENTS? Chairs: Jane MacDonald & Bev Matthews From a patient’s perspective How to ensure you deliver what matters to patients Supporting patient decision making Training patients appropriately to support other patients Panel discussion: to include above plus: |
Alsh VASCULAR ACCESS Chairs: Martin Taal & Alison Cornall Complex access surgery O78 A Survival Analysis of 1200 Vascular Access Procedures 079 Buttonhole Needling Of Arteriovenous Fistulas: A Randomised Controlled Trial O80 Comparison of cutting balloon angioplasty versus conventional balloon angioplasty as the primary treatment of HD access stenosis O81 Risk factors for Catheter Thrombosis: results of a 2 year prospective study O82 Successful use of ionic dialysance based vascular access flow as part of a HD surveillance programme |
Boisdale
DGH nephrology group sponsored session: MAKING RENAL UNITS SAFER FOR PATIENTS What puts renal patients at risk? Achieving patient safety and improvement A renal nurse perpective of patient safety “Getting the boring stuff right” |
Carron
ANIMAL MODELS – WHAT CAN THEY TELL US? (Renal Science) Immunological glomerulonephritis Tubulointerstitial models Experimental peritonitis What is the relevance of animal models to human disease |